Seshu Tyagarajan serves as Executive at Candel Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Seshu Tyagarajan has executed 7 insider transactions totaling $200.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 17, 2024 involved selling 14,851 shares valued at $96.1K.
Seshu Tyagarajan currently holds 146,049 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Seshu Tyagarajan has been a net seller of CADL stock. They have purchased $25.1K and sold $175.7K worth of shares.
Seshu Tyagarajan's most recent insider trade was on Jul 17, 2024, when they sold 14,851 shares at $6.47 per share.
Get notified when new Form 4 filings are submitted
| $5.97 |
| Discretionary |
| Nov 28, 2023 | CADL | $15.6K | Payment | 17,328 | $0.90 | Discretionary |
| Nov 26, 2023 | CADL | $0 | Award | 104,516 | $N/A | Discretionary |
| Dec 9, 2022 | CADL | $20.0K | Purchase | 10,358 | $1.93 | Discretionary |
| Dec 8, 2022 | CADL | $5.1K | Purchase | 3,000 | $1.69 | Discretionary |
| Nov 28, 2022 | CADL | $0 | Award | 73,684 | $N/A | Discretionary |